Melexis NV (MLXSF)
| Market Cap | 3.52B +41.1% |
| Revenue (ttm) | 972.52M -5.1% |
| Net Income | 127.98M -22.4% |
| EPS | 3.16 -22.6% |
| Shares Out | n/a |
| PE Ratio | 27.53 |
| Forward PE | 22.77 |
| Dividend | 1.50 (2.14%) |
| Ex-Dividend Date | Oct 14, 2025 |
| Volume | 200 |
| Average Volume | 781 |
| Open | 70.15 |
| Previous Close | 76.00 |
| Day's Range | 70.15 - 76.00 |
| 52-Week Range | 56.23 - 88.28 |
| Beta | 1.51 |
| RSI | 54.52 |
| Earnings Date | Apr 29, 2026 |
About Melexis NV
Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle East, Africa, the Asia Pacific, and North and Latin America. The company provides current, inductive position, latch and switch, magnetic position, speed, optical, pressure, temperature motor, and tire monitoring sensors ICs, as well as time-of-flight ICs; embedded motor, fan and pump, smart LED, pre-driver, and transceivers ICs, such as LIN, CAN, and RFID transceivers; and embedded lighting ICs.... [Read more]
Financial Performance
In 2025, Melexis NV's revenue was 839.62 million, a decrease of -9.99% compared to the previous year's 932.81 million. Earnings were 112.51 million, a decrease of -34.38%.
Financial numbers in EUR Financial StatementsNews
Melexis price target raised to EUR 82 from EUR 70 at Berenberg
Berenberg raised the firm’s price target on Melexis (MLXSF) to EUR 82 from EUR 70 and keeps a Buy rating on the shares.
Melexis price target raised to EUR 67 from EUR 60 at JPMorgan
JPMorgan analyst Craig McDowell raised the firm’s price target on Melexis (MLXSF) to EUR 67 from EUR 60 and keeps a Neutral rating on the shares.
Melexis NV (MLXSF) Q1 2026 Earnings Call Highlights: Navigating Exchange Rate Challenges and ...
Melexis NV (MLXSF) Q1 2026 Earnings Call Highlights: Navigating Exchange Rate Challenges and Expanding in China
Q1 2026 Melexis NV Earnings Call Transcript
Q1 2026 Melexis NV Earnings Call Transcript
Melexis NV Earnings Call Transcript: Q1 2026
Q1 2026 saw 2% sales growth and improved profitability, with automotive applications driving 89% of sales. Guidance for H1 2026 is flat year-over-year, with sequential growth expected in H2. Strategic expansion in China and new product launches in robotics and data centers are underway.
Melexis Q1 2026 results
Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - April 29th, 2026, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: https://...
Melexis: update on the share buy-back program
Press release - Regulated Information Ieper, Belgium – 30 March 2026, 17.45 hrs CET Melexis reports the purchase of 24,000 Melexis shares on Euronext Brussels in the period from 23 March 2026 to 27 Ma...
Melexis Strengthens Commitment to China with New Wholly Foreign-Owned Enterprise (WFOE) and Autonomous Regional Organization
Tessenderlo-Ham, Belgium – 12 March 2026 – Melexis (Euronext Brussels: MELE), a global leader in micro-electronic semiconductor solutions, today announced the formal establishment of Melexis Integrate...
Melexis price target lowered to EUR 60 from EUR 73 at JPMorgan
JPMorgan lowered the firm’s price target on Melexis (MLXSF) to EUR 60 from EUR 73 and keeps a Neutral rating on the shares.
Melexis price target lowered to EUR 70 from EUR 75 at Berenberg
Berenberg lowered the firm’s price target on Melexis (MLXSF) to EUR 70 from EUR 75 and keeps a Buy rating on the shares.
Melexis price target lowered to EUR 65 from EUR 75 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Melexis (MLXSF) to EUR 65 from EUR 75 and keeps a Buy rating on the shares.
Melexis downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley downgraded Melexis (MLXSF) to Equal Weight from Overweight with a price target of EUR 55, down from EUR 80. The company’s fiscal 2026 outlook breaks the narrative of
Melexis NV Earnings Call Transcript: Q4 2025
2025 saw a 10% sales decline but strong Q4 growth in China and APAC, with robust innovation and strategic expansion in China and India. 2026 is expected to be flat in H1 with growth in H2, gross margin improvement, and continued volatility, especially in China.
Melexis Q4 and FY 2025 results
Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - February 4th, 2026, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: https:...
Melexis price target raised to EUR 73 from EUR 70 at JPMorgan
JPMorgan analyst Craig McDowell raised the firm’s price target on Melexis (MLXSF) to EUR 73 from EUR 70 and keeps a Neutral rating on the shares.
Melexis: Launch of a new share buy-back program
Press release - Regulated Information Ieper, Belgium – 10 December 2025, 07.00 hrs CET - Melexis NV (Euronext Brussels: MELE) (“Melexis”) announces a new share buy-back program. The share buy-back pro...
Melexis NV Transcript: CMD 2025
The event outlined a strategy focused on innovation, diversification, and operational excellence, with a strong push into non-automotive markets like Robotics and Alternative Mobility. Financial targets include high single-digit growth, margin improvement, and a robust balance sheet, while China remains a key market for future expansion.
Melexis NV Earnings Call Transcript: Q3 2025
Q3 2025 sales reached €215.3M, slightly above guidance but down 13% year-over-year, with sequential growth led by Europe and strong traction in Asia. Gross margin was 38.8%, impacted by resolved ramp-up issues, and full-year sales are expected at €840–€845M.
Melexis Q3 2025 results
Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - October 29th, 2025, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: http...
Melexis NV Earnings Call Transcript: Q2 2025
Sequential sales growth in Q2 was driven by strong performance in China and EMEA, with automotive applications leading. Full-year guidance was reinstated amid limited visibility, and gross margin was impacted by nonrecurring costs and FX.
Melexis Q2 2025 results
Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - July 30th, 2025, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: https://w...
Melexis Appoints Two New Directors to Its Board of Directors
Tessenderlo-Ham, Belgium – May 15, 2025 Melexis NV (Euronext Brussels: MELE), a global supplier of micro-electronic semiconductor solutions, announces the appointment of two new members to the board o...
Melexis NV Earnings Call Transcript: Q1 2025
Q1 2025 sales fell 18% year-over-year to €198.2M, with gross margin at 38.2% and net income down 54%. Strategic focus is on innovation and China, with inventory build-up to capture future demand. H1 2025 sales are guided at €400M amid ongoing market uncertainty.
Melexis Q1 2025 results – First quarter sales of 198.2 million EUR
Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - April 30th, 2025, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: https://...
Melexis NV Earnings Call Transcript: Q4 2024
2024 sales declined 3% to €932.8 million, with Q4 down sharply due to inventory corrections and order push-outs. Strong design wins, especially in China and robotics, position for growth, with recovery expected mid-2025 and a €3.7/share dividend proposed.